Clinical Trial Update: Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata

View source ↗

Summary

A clinical trial is investigating whether serum VEGF-A and VCAM-1 levels associate with nailfold capillary alterations in patients with Alopecia Areata. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Snippet

Sponsor: Istanbul Training and Research Hospital | Conditions: Alopecia Areata, Alopecia Areata(AA) | Status: ENROLLING_BY_INVITATION